Takeda: Collaborating for change: unlocking the potential of a cutting-edge GI therapy

Takeda, a pharmaceutical company, developed a high-level framework for its communications campaign about a new gastrointestinal therapy.


"At the beginning, we thought this was a million-and-one-piece puzzle. In partnership with Incite we managed to solve it." Director Global Customer Insights

Introducing innovative new treatments can be challenging, especially if they do not fit neatly with the current patient management paradigm.